miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC

References

• Nooreldeen R, Bach H. Current and future development in lung cancer diagnosis. Int J Mol Sci. 2021;22:16. doi:10.3390/ijms22168661
   Google Scholar
• Wan L, Cheng Z, Sun Q, et al. LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-96. Expert Rev Respir Med. 2022;16(5):587–593. doi:10.1080/17476348.2022.2030223
   PubMed Web of Science ®Google Scholar
• Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40–46. doi:10.1097/CCO.0000000000000703
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu Y, Li S, et al. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol. 2021;147(8):2177–2186. doi:10.1007/s00432-021-03644-0
   PubMed Web of Science ®Google Scholar
• Imyanitov EN, Iyevleva AG, Levchenko EV. Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives. Crit Rev Oncol Hematol. 2021;157:103194. doi:10.1016/j.critrevonc.2020.103194
   PubMed Web of Science ®Google Scholar
• Flemming JP, Hill BL, Haque MW, et al. miRNA- and cytokine-associated extracellular vesicles mediate squamous cell carcinomas. J Extracell Vesicles. 2020;9(1):1790159. doi:10.1080/20013078.2020.1790159
   PubMed Web of Science ®Google Scholar
• He R, Feng X, Yang K, et al. Construction of a 5-methylcytosine-related molecular signature to inform the prognosis and immunotherapy of lung squamous cell carcinoma. Expert Rev Mol Diagn. 2022;22(9):905–913. doi:10.1080/14737159.2022.2131396
   PubMed Web of Science ®Google Scholar
• Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14:4. doi:10.1242/dmm.047662
   Web of Science ®Google Scholar
• Pawlick JS, Zuzic M, Pasquini G, et al. MiRNA regulatory functions in photoreceptors. Front Cell Dev Biol. 2020;8:620249. doi:10.3389/fcell.2020.620249
   PubMed Web of Science ®Google Scholar
• Kujtan L, Kancha RK, Gustafson B, et al. Squamous cell carcinoma of the lung: improving the detection and management of immune-related adverse events. Expert Rev Anticancer Ther. 2022;22(2):203–213. doi:10.1080/14737140.2022.2029414
   PubMed Web of Science ®Google Scholar
• Gomez-Lopez S, Whiteman ZE, Janes SM. Mapping lung squamous cell carcinoma pathogenesis through in vitro and in vivo models. Commun Biol. 2021;4(1):937. doi:10.1038/s42003-021-02470-x
   PubMed Web of Science ®Google Scholar
• Niu Z, Jin R, Zhang Y, et al. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials. Signal Transduct Target Ther. 2022;7(1):353. doi:10.1038/s41392-022-01200-x
   PubMed Web of Science ®Google Scholar
• Pan Y, Han H, Labbe KE, et al. Recent advances in preclinical models for lung squamous cell carcinoma. Oncogene. 2021;40(16):2817–2829. doi:10.1038/s41388-021-01723-7
   PubMed Web of Science ®Google Scholar
• Du F, Cao T, Xie H, et al. KRAS mutation-responsive miR-139-5p inhibits colorectal cancer progression and is repressed by wnt signaling. Theranostics. 2020;10(16):7335–7350. doi:10.7150/thno.45971
   PubMed Web of Science ®Google Scholar
• Miyoshi J, Toden S, Yoshida K, et al. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Sci Rep. 2017;7:43393. doi:10.1038/srep43393
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang T, Chen Y, et al. MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression. Biosci Rep. 2020;40(5). doi:10.1042/BSR20193295
   Google Scholar
• Uchida A, Seki N, Mizuno K, et al. Regulation of KIF2A by antitumor miR-451a inhibits cancer cell aggressiveness features in lung squamous cell carcinoma. Cancers. 2019;11:2. doi:10.3390/cancers11020258
   Web of Science ®Google Scholar
• Editors PO. Expression of Concern: the low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases. PLoS One. 2023;18(1):e0280774.
   PubMed Web of Science ®Google Scholar
• Fan B, Jin X, Ding Q, et al. Expression of miR-451a in prostate cancer and its effect on prognosis. Iran J Public Health. 2021;50(4):772–779. doi:10.18502/ijph.v50i4.6002
   PubMed Web of Science ®Google Scholar
• Zhao F, Wei C, Cui MY, et al. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis. Aging. 2020;12(10):9380–9404. doi:10.18632/aging.103214
   PubMedGoogle Scholar
• Zhong L, Xu Z, Jin X, et al. miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma. Oncol Lett. 2020;20(6):339. doi:10.3892/ol.2020.12202
   PubMed Web of Science ®Google Scholar
• Zhong L, Jin X, Xu Z, et al. Circulating miR-451a levels as a potential biomarker to predict the prognosis of patients with multiple myeloma. Oncol Lett. 2020;20(5):263. doi:10.3892/ol.2020.12126
   PubMed Web of Science ®Google Scholar
• Wang X, Gao J, Zhou B, et al. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles. Life Sci. 2019;232:116596. doi:10.1016/j.lfs.2019.116596
   PubMed Web of Science ®Google Scholar
• Bao B, Yu X, Zheng W. MiR-139-5p Targeting CCNB1 modulates proliferation, migration, invasion and cell cycle in lung adenocarcinoma. Mol Biotechnol. 2022;64(8):852–860. doi:10.1007/s12033-022-00465-5
   PubMed Web of Science ®Google Scholar
• Jiao W, Zhang J, Wei Y, et al. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer. Dig Liver Dis. 2019;51(1):149–156. doi:10.1016/j.dld.2018.07.017
   PubMedGoogle Scholar
• Chen J, Yu Y, Chen X, et al. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Prolif. 2018;51(6):e12510. doi:10.1111/cpr.12510
   PubMed Web of Science ®Google Scholar
• Niveditha D, Jasoria M, Narayan J, et al. Common and unique microRNAs in multiple carcinomas regulate similar network of pathways to mediate cancer progression. Sci Rep. 2020;10(1):2331. doi:10.1038/s41598-020-59142-9
   PubMed Web of Science ®Google Scholar
• Li J, Li Q, Lin L, et al. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT). BMC Neurol. 2018;18(1):133. doi:10.1186/s12883-018-1139-8
   PubMed Web of Science ®Google Scholar
• Lu H, Liu Y, Wang J, et al. Detection of ovarian cancer using plasma cell-free DNA methylomes. Clin Epigenetics. 2022;14(1):74. doi:10.1186/s13148-022-01285-9
   PubMed Web of Science ®Google Scholar